Non-Dilutive Funding —AN EXCELLENT OPTION FOR BIOTECH STARTUPS
Non-dilutive funding is often under-utilized by biotechs, even though this type of funding is more accessible in the life sciences than in other sectors, given government interest in improving public health. Below, we outline excellent sources of non-dilutive funding. These funding mechanisms can be coordinated with the selection of a biologics contract development and manufacturing organization (CDMO) to advance your mammalian, microbial, or cell therapy program to clinical trials.
Non-Dilutive Funding —AN EXCELLENT OPTION FOR BIOTECH STARTUPS